| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,559 |
17,557 |
$2.44M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,248 |
22,276 |
$1.95M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,937 |
9,418 |
$1.61M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,091 |
3,885 |
$638K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,963 |
5,580 |
$230K |
| 71045 |
Radiologic examination, chest; single view |
9,506 |
9,001 |
$229K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,202 |
1,136 |
$227K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,985 |
11,270 |
$212K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,163 |
27,333 |
$200K |
| 80053 |
Comprehensive metabolic panel |
24,489 |
22,517 |
$180K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,304 |
2,238 |
$156K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
198 |
187 |
$122K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,597 |
1,348 |
$98K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,874 |
3,637 |
$96K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,839 |
1,245 |
$89K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,776 |
3,061 |
$82K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,364 |
1,180 |
$77K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,179 |
978 |
$73K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,408 |
3,086 |
$72K |
| 71046 |
Radiologic examination, chest; 2 views |
1,457 |
1,435 |
$65K |
| 0225U |
|
177 |
155 |
$64K |
| J3490 |
Unclassified drugs |
15,547 |
8,561 |
$62K |
| 84484 |
|
7,416 |
6,720 |
$60K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
984 |
970 |
$56K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
70 |
66 |
$46K |
| 81001 |
|
13,334 |
12,610 |
$37K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
806 |
643 |
$32K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
911 |
267 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
325 |
296 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
15,135 |
13,898 |
$25K |
| 83690 |
|
3,780 |
3,534 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,721 |
1,430 |
$22K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
42 |
39 |
$18K |
| 81025 |
|
2,214 |
2,063 |
$18K |
| 82552 |
|
2,120 |
2,044 |
$18K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
350 |
196 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,026 |
1,942 |
$15K |
| 85730 |
|
3,162 |
3,060 |
$12K |
| Q0092 |
Set-up portable x-ray equipment |
3,911 |
3,791 |
$12K |
| 85610 |
|
4,085 |
3,930 |
$10K |
| J1756 |
Injection, iron sucrose, 1 mg |
72 |
29 |
$9K |
| 83735 |
|
1,536 |
1,456 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,862 |
828 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,184 |
1,083 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
215 |
207 |
$8K |
| 94760 |
|
1,864 |
1,735 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
93 |
91 |
$7K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,204 |
1,910 |
$7K |
| 82728 |
|
580 |
532 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
200 |
182 |
$6K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
428 |
229 |
$6K |
| 11043 |
|
109 |
63 |
$5K |
| 11045 |
|
129 |
69 |
$5K |
| 84466 |
|
496 |
469 |
$5K |
| 83605 |
|
518 |
481 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
96 |
90 |
$4K |
| 87400 |
|
169 |
163 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
188 |
180 |
$3K |
| 87040 |
|
216 |
213 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,261 |
1,095 |
$3K |
| 83880 |
|
115 |
114 |
$3K |
| 83540 |
|
499 |
470 |
$3K |
| C1769 |
Guide wire |
109 |
95 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
232 |
208 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
449 |
412 |
$2K |
| G0378 |
Hospital observation service, per hour |
95 |
51 |
$2K |
| 82607 |
|
151 |
142 |
$1K |
| 87631 |
|
21 |
21 |
$1K |
| 87088 |
|
159 |
150 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
14 |
$1K |
| 82746 |
|
122 |
114 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
158 |
85 |
$1K |
| 82565 |
|
311 |
296 |
$1K |
| 74018 |
|
13 |
12 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
94 |
83 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
12 |
$970.19 |
| 81003 |
|
418 |
382 |
$941.74 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
59 |
53 |
$908.46 |
| 84443 |
Thyroid stimulating hormone (TSH) |
64 |
62 |
$892.16 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
105 |
98 |
$733.45 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
71 |
60 |
$718.59 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
52 |
51 |
$706.18 |
| 93041 |
|
73 |
63 |
$629.91 |
| 86850 |
|
76 |
67 |
$567.95 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
198 |
147 |
$528.27 |
| 87581 |
|
21 |
21 |
$520.31 |
| 87486 |
|
21 |
21 |
$520.31 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
75 |
63 |
$494.00 |
| 96376 |
|
42 |
39 |
$481.02 |
| 84100 |
|
143 |
140 |
$445.47 |
| 80076 |
|
87 |
86 |
$399.54 |
| 82077 |
|
137 |
116 |
$397.99 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
12 |
$388.12 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
215 |
152 |
$383.50 |
| 96367 |
|
29 |
13 |
$355.49 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
130 |
123 |
$338.37 |
| 82962 |
|
93 |
86 |
$321.10 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
24 |
24 |
$287.67 |
| 80061 |
Lipid panel |
30 |
25 |
$275.08 |
| V2632 |
Posterior chamber intraocular lens |
14 |
13 |
$273.94 |
| 84165 |
|
60 |
53 |
$271.45 |
| 82378 |
|
14 |
13 |
$211.76 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
157 |
109 |
$210.64 |
| 87186 |
|
27 |
24 |
$179.80 |
| 87077 |
|
29 |
25 |
$176.56 |
| 83521 |
|
60 |
53 |
$136.10 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
12 |
$133.34 |
| 83615 |
|
37 |
29 |
$126.04 |
| 83010 |
|
18 |
12 |
$108.40 |
| 87807 |
|
14 |
14 |
$104.93 |
| 82247 |
|
13 |
12 |
$85.41 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
45 |
41 |
$71.85 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
28 |
24 |
$59.11 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
13 |
13 |
$28.29 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
280 |
228 |
$25.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
13 |
$19.74 |
| 86900 |
|
14 |
12 |
$12.85 |
| 86901 |
|
14 |
12 |
$12.85 |